Atacicept

Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)

The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis

Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

Atacicept in Subjects With Optic Neuritis

A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)

Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)

Atacicept Demonstrating Dose RESponSe

A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN)

A Multicenter, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Atacicept in Multiple Glomerular Diseases

Monthly Dosing of Atacicept in IgAN

A Phase 2 Study to Evaluate the Safety and Efficacy of Atacicept in Multiple Autoimmune Glomerular Diseases (PIONEER)

A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients with IgAN

A randomised, double-blind, placebo-controlled, multicentre prospective dose-finding Phase II/III study with atacicept given subcutaneously to subjects having recently experienced a flare of systemic lupus erythematosus (SLE)

Atacicept in Subjects With IgA Nephropathy

Atacicept in Subjects With Active Lupus Nephritis (COMPASS)